Oscar Health (OSCR) Stock Price

Oscar Health Price

NYSE·CLOSED
30.91USD-0.82 (-2.62 %)
Market closed

Revenue has compounded at 66.8% per year over the past 6 years to 11.68 B USD. Oscar Health's net margin stands at -3.8%, up from -30.0% several years earlier. Analysts set a median price target of 17.34 USD, implying 43.9% below the current price. Of 17 analysts, 3 rate the stock a buy — an overall Hold consensus. The stock trades about 185% above its 52-week low.

Oscar Health stock price

Volume
Details

Stock Price

How to Read This Chart

This chart tracks the historical stock price of Oscar Health over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Oscar Health stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Oscar Health's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Oscar Health Stock Price History
DateOscar Health Price
8/19/202630.91 USD
8/18/202631.73 USD
8/14/202632.76 USD
8/13/202630.78 USD
8/12/202628.64 USD
8/10/202628.22 USD
8/7/202627.90 USD
8/6/202626.54 USD
8/5/202630.81 USD
8/4/202630.24 USD
8/3/202630.74 USD
7/31/202631.22 USD
7/30/202631.23 USD
7/29/202631.14 USD
7/27/202628.91 USD
7/23/202628.92 USD
7/22/202629.50 USD
7/21/202630.77 USD
7/20/202629.60 USD
7/17/202629.10 USD
7/16/202628.86 USD
7/15/202630.61 USD
7/14/202631.07 USD
7/13/202631.60 USD
7/10/202630.54 USD
7/9/202631.20 USD
7/8/202631.57 USD
7/7/202631.12 USD
7/6/202631.38 USD
7/2/202632.18 USD
7/1/202631.90 USD
6/30/202628.52 USD
6/29/202629.08 USD
6/26/202629.79 USD
6/25/202628.67 USD
6/24/202629.16 USD
6/23/202629.93 USD
6/22/202629.17 USD
6/18/202627.83 USD
6/17/202629.30 USD
6/16/202628.44 USD
6/15/202628.20 USD
6/12/202628.11 USD
6/11/202628.26 USD
6/10/202628.03 USD
6/9/202627.22 USD
6/8/202627.39 USD
6/5/202623.75 USD
6/4/202623.50 USD
6/3/202620.43 USD
6/2/202621.94 USD
6/1/202622.68 USD
5/29/202622.15 USD
5/28/202622.52 USD
5/27/202622.34 USD
5/26/202622.05 USD
5/22/202622.39 USD
5/21/202622.70 USD
5/20/202623.93 USD
5/19/202624.52 USD
5/18/202625.30 USD
5/15/202623.32 USD
5/14/202623.15 USD
5/13/202623.62 USD
5/12/202623.73 USD
5/11/202622.00 USD
5/8/202621.31 USD
5/7/202620.87 USD
5/6/202619.84 USD
5/5/202617.94 USD
5/4/202618.57 USD
5/1/202618.49 USD
4/30/202618.46 USD
4/29/202617.93 USD
4/28/202618.04 USD
4/27/202617.18 USD
4/24/202616.81 USD
4/23/202616.43 USD
4/22/202616.44 USD
4/21/202616.17 USD
4/20/202616.44 USD
4/17/202615.79 USD
4/16/202615.63 USD
4/15/202615.59 USD
4/14/202615.29 USD
4/13/202615.48 USD
4/10/202614.45 USD
4/9/202614.54 USD
4/8/202614.64 USD
4/7/202612.97 USD
4/6/202612.76 USD
4/2/202611.92 USD
4/1/202611.73 USD
3/31/202611.47 USD
3/30/202610.85 USD
3/27/202611.14 USD
3/26/202611.84 USD
3/25/202612.21 USD
3/24/202612.03 USD
3/23/202612.21 USD
3/20/202612.63 USD
3/19/202613.30 USD
3/18/202613.56 USD
3/17/202613.51 USD
3/16/202613.28 USD
3/13/202613.23 USD
3/12/202613.00 USD
3/11/202613.40 USD
3/10/202613.30 USD
3/9/202613.96 USD
3/6/202613.84 USD
3/5/202614.39 USD
3/4/202615.05 USD
3/3/202613.67 USD
3/2/202613.98 USD
2/27/202613.64 USD
2/26/202613.66 USD
2/25/202612.95 USD
2/24/202612.30 USD
2/23/202612.45 USD
2/20/202613.23 USD
2/19/202613.73 USD
2/18/202613.70 USD
2/17/202613.39 USD
2/13/202613.42 USD
2/12/202613.71 USD
2/11/202613.60 USD
2/10/202612.88 USD
2/9/202612.66 USD
2/6/202612.24 USD
2/5/202612.51 USD
2/4/202613.22 USD
2/3/202613.91 USD
2/2/202614.00 USD
1/30/202614.35 USD
1/29/202614.93 USD
1/28/202614.87 USD
1/27/202614.88 USD
1/26/202615.70 USD
1/23/202615.68 USD
1/22/202615.69 USD
1/21/202615.40 USD
1/20/202615.92 USD
1/16/202616.55 USD
1/15/202617.42 USD
1/14/202616.69 USD
1/13/202617.38 USD
1/12/202617.66 USD
1/9/202617.73 USD
1/8/202616.90 USD
1/7/202616.48 USD
1/6/202616.52 USD
1/5/202616.57 USD
1/2/202614.97 USD
12/31/202514.37 USD
12/30/202514.51 USD
12/29/202514.53 USD
12/26/202514.91 USD
12/24/202514.93 USD
12/23/202514.84 USD
12/22/202515.03 USD
12/19/202514.90 USD
12/18/202514.80 USD
12/17/202515.39 USD
12/16/202515.71 USD
12/15/202516.14 USD
12/12/202516.63 USD
12/11/202515.87 USD
12/10/202515.59 USD
12/9/202516.96 USD
12/8/202516.73 USD
12/5/202516.77 USD
12/4/202517.18 USD
12/3/202517.10 USD
12/2/202516.85 USD
12/1/202516.65 USD
11/28/202517.97 USD
11/26/202518.16 USD
11/25/202516.73 USD
11/24/202516.49 USD
11/21/202513.48 USD
11/20/202513.03 USD
11/19/202514.08 USD
11/18/202514.71 USD
11/17/202514.25 USD
11/14/202513.88 USD
11/13/202513.95 USD
11/12/202515.10 USD
11/11/202514.85 USD
11/10/202514.61 USD
11/7/202517.72 USD
11/6/202516.56 USD
11/5/202517.03 USD
11/4/202517.16 USD
11/3/202517.66 USD
10/31/202518.00 USD
10/30/202518.09 USD
10/29/202518.91 USD
10/28/202519.54 USD
10/27/202519.67 USD
10/24/202519.29 USD
10/23/202519.62 USD
10/22/202520.37 USD
10/21/202521.77 USD
10/20/202520.18 USD
10/17/202519.39 USD
10/16/202521.03 USD
10/15/202520.67 USD
10/14/202520.69 USD
10/13/202520.40 USD
10/10/202518.77 USD
10/9/202520.54 USD
10/8/202521.80 USD
10/7/202522.47 USD
10/6/202522.31 USD
10/3/202521.66 USD
10/2/202519.28 USD
10/1/202518.90 USD
9/30/202518.93 USD
9/29/202519.13 USD
9/26/202518.42 USD
9/25/202518.09 USD
9/24/202518.44 USD
9/23/202517.76 USD
9/22/202518.50 USD
9/19/202518.97 USD
9/18/202519.11 USD
9/17/202517.77 USD
9/16/202517.93 USD
9/15/202518.73 USD
9/12/202519.33 USD
9/11/202519.43 USD
9/10/202519.48 USD
9/9/202520.05 USD
9/8/202520.28 USD
9/5/202519.43 USD
9/4/202518.38 USD
9/3/202517.68 USD
9/2/202516.43 USD
8/29/202516.66 USD
8/28/202517.24 USD
8/27/202517.02 USD
8/26/202517.08 USD
8/25/202516.71 USD
8/22/202516.80 USD
Access this data via the Eulerpool API

Oscar Health Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
5.84 B USD
-242.78 M USD
-270.73 M USD
Jan 1, 2024
9.15 B USD
57.27 M USD
25.43 M USD
Jan 1, 2025
11.68 B USD
-419.70 M USD
-443.15 M USD
Jan 1, 2026 (e)
18.59 B USD
-1.88 B USD
472.46 M USD
Jan 1, 2027 (e)
19.91 B USD
-2.02 B USD
483.24 M USD
Jan 1, 2028 (e)
22.11 B USD
-2.25 B USD
582.50 M USD
Jan 1, 2029 (e)
24.60 B USD
-2.50 B USD
687.46 M USD
Jan 1, 2030 (e)
27.43 B USD
-2.79 B USD
795.04 M USD

Oscar Health Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 21, 2026, 10:41 PM
 
REVENUEB USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB USD
EBITB USD
EBIT MARGIN%
NET INCOMEM USD
NET INCOME GROWTH%
SHARESM
20192020202120222023202420252026e2027e2028e2029e2030e
0.550.591.924.135.869.1811.7018.5919.9122.1124.6027.43
6.51225.98114.8442.1156.5527.5058.917.1011.0011.3011.51
100.00100.00100.00100.00100.0020.0914.3714.3714.3714.3714.3714.37
0.550.591.924.135.861.841.682.672.863.183.543.94
-0.26-0.40-0.57-0.59-0.240.06-0.42-1.88-2.02-2.25-2.50-2.79
-46.84-68.25-29.43-14.23-4.130.62-3.58-10.12-10.13-10.16-10.16-10.16
-261.00-406.00-572.00-606.00-270.0025.00-443.00472.00483.00582.00687.00795.00
55.5640.895.94-55.45-109.26-1,872.00-206.552.3320.5018.0415.72
29.0030.23209.78215.19227.08265.85283.25283.25283.25283.25283.25283.25
Details

Income Statement Key Figures

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Oscar Health generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Oscar Health retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Oscar Health's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Oscar Health has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Oscar Health's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Oscar Health stock margins

The Oscar Health margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Oscar Health. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Oscar Health.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
100.79 %
-29.69 %
-30.04 %
Jan 1, 2022
101.32 %
-14.43 %
-14.89 %
Jan 1, 2023
100.42 %
-4.16 %
-4.64 %
Jan 1, 2024
20.16 %
0.63 %
0.28 %
Jan 1, 2025
14.40 %
-3.59 %
-3.79 %
Jan 1, 2026 (e)
14.40 %
-10.12 %
2.54 %
Jan 1, 2027 (e)
14.40 %
-10.14 %
2.43 %
Jan 1, 2028 (e)
14.40 %
-10.16 %
2.64 %

Oscar Health Stock Revenue, EBIT, Earnings per Share

The Oscar Health earnings per share therefore indicates how much revenue Oscar Health has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
9.09 USD
-2.70 USD
-2.73 USD
Jan 1, 2022
18.92 USD
-2.73 USD
-2.82 USD
Jan 1, 2023
25.71 USD
-1.07 USD
-1.19 USD
Jan 1, 2024
34.43 USD
0.22 USD
0.10 USD
Jan 1, 2025
41.25 USD
-1.48 USD
-1.56 USD
Jan 1, 2026 (e)
70.87 USD
-6.64 USD
1.80 USD
Jan 1, 2027 (e)
75.90 USD
-7.13 USD
1.84 USD
Jan 1, 2028 (e)
84.25 USD
-7.93 USD
2.22 USD

Oscar Health business model & stock analysis

Oscar Health Inc is a US-American company that was founded in 2012 by Mario Schlosser, Kevin Nazemi, and Josh Kushner. The company's goal is to simplify and improve healthcare in the USA. Oscar Health offers health insurance, a digital health platform, and telemedicine. The business model of Oscar Health is based on the idea of integrating the entire healthcare system into a digital platform to facilitate and make patient treatment more effective. Oscar Health collects and analyzes health and well-being data from its policyholders and uses this information to offer personalized treatment options and recommendations. As a health insurance company, Oscar Health offers various plans tailored to the needs of customers. Oscar Health plans include basic coverage, comprehensive coverage, and high-end plans. All of them offer a wide range of services, including hospital care, doctor visits, emergency care, and medication. Oscar Health also has a special offer for employees of companies who need assistance with managing business insurance. They also provide special offers for self-employed individuals. With the Oscar app, customers can manage their health information and insurance benefits. They can directly contact healthcare professionals through the app, schedule appointments, or order prescriptions. These features are part of Oscar Health's efforts to simplify the healthcare process and make it more customer-friendly. The company has also invested in telemedicine to improve customer access to medical services. Telemedicine allows patients to contact healthcare professionals and receive diagnoses via the internet. This means that patients can access healthcare professionals and treatments without the hassle of a doctor's visit. Oscar Health has also invested in the creation of clinics and is currently operating in New York City and Houston. These clinics offer a range of healthcare services including doctor visits, laboratory tests, and vaccinations. Patients can also have telemedicine sessions with healthcare professionals at the clinic. Overall, since its founding in 2012, Oscar Health has played a significant role in reforming the US healthcare system. The company has managed to create a digital platform that simplifies the healthcare process for many Americans and provides a better customer experience. The various offerings of Oscar Health, such as telemedicine, clinics, and personalized treatment options, allow customers to access a wide range of medical services.

Oscar Health SWOT Analysis

Strengths

One of Oscar Health Inc's strengths is its innovative healthcare technology platform, which allows for streamlined and personalized health insurance experiences for its customers.

Another strength is Oscar Health Inc's focus on preventive care and wellness programs, promoting healthier lifestyles and reducing overall healthcare costs.

The company's strong network of healthcare providers and partnerships enables customers to have access to high-quality medical services.

Weaknesses

Oscar Health Inc faces the challenge of operating in a highly regulated industry, which may limit its flexibility and increase compliance costs.

The company's limited geographical presence compared to larger health insurance providers could hinder its ability to compete on a national scale.

Oscar Health Inc's relatively short operating history may lead to uncertainty and skepticism among potential customers and investors.

Opportunities

With the increasing demand for digital healthcare solutions, Oscar Health Inc can leverage its technological capabilities to capture a larger market share.

Expanding into new geographic regions or partnering with regional health insurance providers can help Oscar Health Inc broaden its customer base.

The growing focus on value-based healthcare and alternative payment models presents an opportunity for Oscar Health Inc to differentiate itself and attract customers.

Threats

Intense competition from well-established health insurance companies with larger resources and brand recognition poses a threat to Oscar Health Inc's market position.

Changes in healthcare regulations or policies could disrupt Oscar Health Inc's business model and require significant adjustments.

Public perception and trust in the use of technology for healthcare-related services may impact the adoption rate of Oscar Health Inc's digital platform.

Oscar Health Employees

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Oscar Health Employees
Details
Date
Oscar Health Employees
Jan 1, 2021
- Employees
Jan 1, 2022
- Employees
Jan 1, 2023
- Employees
Jan 1, 2024
- Employees
Jan 1, 2025
- Employees

Oscar Health Segments

Oscar Health Eulerpool Fair Value

Details

Fair Value Estimate

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Oscar Health historical P/E ratio, EBIT multiple, and P/S ratio

Oscar Health annual returns

Details

Annual Return

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Oscar Health shares outstanding

The number of shares of Oscar Health was 283.25 M in 2025. This indicates how many shares Oscar Health is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
209.78 M Stocks
Jan 1, 2022
215.19 M Stocks
Jan 1, 2023
227.08 M Stocks
Jan 1, 2024
265.85 M Stocks
Jan 1, 2025
283.25 M Stocks
Jan 1, 2026 (e)
283.25 M Stocks
Jan 1, 2027 (e)
283.25 M Stocks
Jan 1, 2028 (e)
283.25 M Stocks

Current Oscar Health forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
17.65 % (3)
Hold
47.06 % (8)
Sell
35.29 % (6)
12M Price Target
17.34
Last Price
31.57
Currency
USD
12M Return Potential
-45.07 %
LTM Return
0 %

Oscar Health Analyst Rating Actions

DateFirmActionRatingReliability
8/13/2026
Wells Fargo
Wells Fargo
MaintainedEqual Weight53
8/7/2026
UBS
UBS
MaintainedNeutral50
8/7/2026
Barclays
Barclays
MaintainedOverweight57
6/10/2026
Barclays
Barclays
UpgradeEqual WeightOverweight57
5/26/2026
Barclays
Barclays
MaintainedEqual Weight57
5/7/2026
UBS
UBS
MaintainedNeutral50
5/7/2026
Barclays
Barclays
MaintainedEqual Weight57
5/7/2026
Baird
Baird
MaintainedNeutral56
4/20/2026
Jefferies
Jefferies
UpgradeUnderperformHold57
1/9/2026
UBS
UBS
UpgradeSellNeutral50

Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.

Oscar Health Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
8/6/20260.31USD-4.83 BUSD-2026 Q2
5/6/20261.18USD-5.01 BUSD-2026 Q1
2/10/2026-0.91USD-3.19 BUSD-2025 Q4
5/7/20240.17USD-1.67 BUSD-2024 Q1
2/7/2024-0.74USD-1.46 BUSD-2023 Q4
11/6/2023-0.55USD-1.35 BUSD-2023 Q3
8/9/2023-0.21USD-1.23 BUSD-2023 Q2
5/8/20230.00USD-1.14 BUSD-2023 Q1
2/8/2023-1.03USD-1.01 BUSD-2022 Q4
11/8/2022-0.75USD-976.60 MUSD-2022 Q3

EESG©

Eulerpool ESG Scorecard© for the Oscar Health stock

27/100
7
Environment
51
Social
22
Governance
E

Environment

20
Scope 1 - Direct Emissions
Scope 2 - Indirect emissions from purchased energy
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees65
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Oscar Health shareholder structure

% Name
7.87155%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
6.59692%
BLACKROCK, INC.
BLACKROCK, INC.
5.47236%
BlackRock Institutional Trust Company, N.A.
BlackRock Institutional Trust Company, N.A.
4.43789%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC.
T. ROWE PRICE INVESTMENT MANAGEMENT, INC.
4.10752%
VANGUARD CAPITAL MANAGEMENT LLC
VANGUARD CAPITAL MANAGEMENT LLC
4.01918%
VANGUARD PORTFOLIO MANAGEMENT LLC
VANGUARD PORTFOLIO MANAGEMENT LLC
...

Oscar Health Beneficial Ownership Filings (SEC 13D/G)

Free Float
96.1%
Float Shares
-
Shares Outstanding
-
StakeHolderFiling
13.80%
Alphabet Inc.
Alphabet Inc.
SEC ↗
11.00%
Baillie Gifford & Co (Scottish partnership)
Baillie Gifford & Co (Scottish partnership)
SEC ↗
8.30%
Kenneth Chenault
Kenneth Chenault
SEC ↗
8.30%
Joel E. Cutler
Joel E. Cutler
SEC ↗
8.30%
Hemant Taneja
Hemant Taneja
SEC ↗
8.30%
General Catalyst Partners X – Growth Venture, L.P.
General Catalyst Partners X – Growth Venture, L.P.
SEC ↗
8.30%
General Catalyst Partners VI, L.P.
General Catalyst Partners VI, L.P.
SEC ↗
8.30%
General Catalyst Group Management, LLC
General Catalyst Group Management, LLC
SEC ↗
8.30%
General Catalyst Group Management Holdings GP, LLC
General Catalyst Group Management Holdings GP, LLC
SEC ↗
8.30%
General Catalyst GP X – Growth Venture, LLC
General Catalyst GP X – Growth Venture, LLC
SEC ↗

Oscar Health Executives and Management Board

13 members · avg. age 54 · 31 % women

RB

Mr. R. Scott Blackley (56)

Chief Financial Officer

5.45 M USD

Management

RB

Ms. Ranmali Bopitiya (42)

Executive Vice President - Public Affairs

3.17 M USD
MS

Mr. Mario Schlosser (46)

Co-Founder, President - Technology, Chief Technology Officer, Director · since 2012

1.66 M USD
MB

Mr. Mark Bertolini (68)

Chief Executive Officer, Director · since 2023

915,000.00 USD
JL

Ms. Janet Liang (57)

President - Oscar Insurance

AM

Mr. Adam Mcananey (48)

Chief Legal Officer

Board of Directors

JK

Mr. Joshua Kushner (39)

Vice Chairman of the Board, Co-Founder · since 2012

30.08 M USD
SS

Mr. Siddhartha Sankaran (47)

Independent Director · since 2019

2.14 M USD
JB

Mr. Jeffery Boyd (68)

Independent Chairman of the Board

299,993.00 USD
VW

Ms. Vanessa Wittman (58)

Independent Director

281,243.00 USD
LL

Ms. Laura Lang (69)

Independent Director

269,498.00 USD
DP

Mr. David Plouffe (57)

Independent Director

259,993.00 USD

Oscar Health Supply Chain

Oscar Health Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
4 companies
#Nameβ 1YTrend
1
HCA Healthcare
Customer·Health Care Providers & Services·US
0.62
0.66
0.68
0.50
-0.19
-0.07
2
Signify Health A
Supplier·Health Care Providers & Services·US
0.19
0.56
0.91
0.77
0.85
3
Cigna
Supplier·Customer·Health Care Providers & Services·US
-0.07
-0.62
-0.41
-0.20
-0.38
-0.19
4
Privia Health
Supplier·Health Care Providers & Services·US
-0.51
0
0.67
0.49
0.75

Frequently asked questions about Oscar Health

The business model of Oscar Health Inc. is centered around providing affordable and tech-savvy health insurance solutions. Oscar operates as a health insurance company that leverages technology to streamline the insurance process and enhance customer experience. With a focus on individual and family health plans, Oscar aims to simplify health coverage by utilizing data-driven insights and a user-friendly platform. By combining innovative technology, personalized customer support, and a comprehensive healthcare network, Oscar Health Inc. endeavors to make healthcare more accessible and efficient for its members.

Oscar Health Inc is primarily active in the health insurance industry.

The main competitors of Oscar Health Inc in the market include insurance giants such as Blue Cross Blue Shield, Aetna, Cigna, and UnitedHealthcare.

Oscar Health Inc. is a prominent health insurance company that was founded in 2012. It has rapidly gained recognition for its innovative approach to healthcare services. The company was established by Josh Kushner, Kevin Nazemi, and Mario Schlosser with a vision to provide accessible and transparent healthcare coverage options. Oscar Health Inc. focuses on leveraging technology to enhance customer experience through its user-friendly website and mobile app platforms. The company offers a range of health insurance plans that cater to individuals, families, and small businesses. With an emphasis on personalized care, Oscar Health Inc. strives to simplify the complex world of healthcare for its members.

Some significant milestones achieved by Oscar Health Inc include: its founding in 2012 by Josh Kushner, Kevin Nazemi, and Mario Schlosser; raising over $1 billion in funding; expanding its operations to multiple states across the U.S.; launching its own technology platform to improve customer experience; developing partnerships with prominent healthcare providers and systems; and going public on the New York Stock Exchange in March 2021. Oscar Health Inc has positioned itself as a disruptive force in the health insurance industry, leveraging its innovative approach and technology-driven solutions to provide accessible and personalized healthcare options to its members.

Oscar Health Inc primarily operates in the United States.

Oscar Health Inc is dedicated to transforming healthcare by putting individuals at the center of their own healthcare experience. The company believes in providing accessible, affordable, and personalized health coverage. Oscar Health Inc focuses on preventive care and empowering individuals to make informed decisions about their health. Their corporate philosophy centers around transparency, simplicity, and customer-centricity. By leveraging technology and data, Oscar Health Inc aims to make healthcare more efficient and user-friendly. Through innovative partnerships and a commitment to customer satisfaction, the company strives to enhance the overall quality of healthcare and prioritize the well-being of their members.

Analysts currently set an average price target of 16.00 USD for the Oscar Health stock (median: 17.34 USD), implying -49.3 % versus the latest price. The consensus is based on 17 analyst ratings.

17 analysts currently rate the Oscar Health stock: 3 recommend buying, 8 holding and 6 selling. For 2026, analysts expect Oscar Health to generate revenue of 18.59 B USD and earnings per share of 1.67 USD.

Converted at the current exchange rate, the Oscar Health share trades at 26.46 EUR (30.91 USD).

The Oscar Health share (OSCR) is listed on 1 stock exchanges, including: NYSE (OSCR).

Oscar Health Inc is a US-based company specializing in health insurance. It was founded in 2012 and is headquartered in New York City. The company's goal is to make healthcare simpler and more accessible. Oscar's business model focuses on providing insurance for individuals, families, and small businesses, using a combination of technology and human advice. They utilize data analysis to identify healthcare trends and develop personalized health plans for their customers. Oscar also uses data to reduce healthcare costs and improve the quality of care. Their product offerings include individual plans, family plans, and group plans for small businesses. Customers have the option to manage their health plans online and make inquiries through the Oscar app or website. They also provide personal consultation through certified health advisors over the phone. Oscar collaborates with healthcare providers to offer quality care to their customers. They have their own doctors and medical professionals available to assist customers. Additionally, Oscar encourages customer interaction by providing online forums and communities for customers to exchange information, ask questions, and find support. In summary, Oscar's business model aims to make healthcare more accessible and affordable. By utilizing data, technology, and collaboration with healthcare providers, they strive to reduce costs and improve the quality of care. Their focus on personalized advice and community-building supports customers in addressing their health concerns and needs.

The expected revenue of Oscar Health is 18.59 B USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Oscar Health is 472.46 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Oscar Health is currently 18.53. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Oscar Health stock.

The price-to-sales ratio (P/S) of Oscar Health is currently 0.47. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Oscar Health stock.

The Eulerpool Quality Score for Oscar Health is 1/10.

The ISIN of Oscar Health is US6877931096. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Oscar Health is A2QQXK. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Oscar Health is OSCR. The ticker symbol is used to trade Oscar Health shares on the stock exchange.

Oscar Health paid dividends every year for the past 0 years.

Oscar Health is assigned to the 'Finance' sector.

The dividends of Oscar Health are distributed in USD.